Global Sexually Transmitted Diseases (STD) Diagnostics Market Growth (Status and Outlook) 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
The global Sexually Transmitted Diseases (STD) Diagnostics market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.
LPI (LP Information)' newest research report, the “Sexually Transmitted Diseases (STD) Diagnostics Industry Forecast” looks at past sales and reviews total world Sexually Transmitted Diseases (STD) Diagnostics sales in 2022, providing a comprehensive analysis by region and market sector of projected Sexually Transmitted Diseases (STD) Diagnostics sales for 2023 through 2029. With Sexually Transmitted Diseases (STD) Diagnostics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Sexually Transmitted Diseases (STD) Diagnostics industry.
This Insight Report provides a comprehensive analysis of the global Sexually Transmitted Diseases (STD) Diagnostics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Sexually Transmitted Diseases (STD) Diagnostics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Sexually Transmitted Diseases (STD) Diagnostics market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Sexually Transmitted Diseases (STD) Diagnostics and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Sexually Transmitted Diseases (STD) Diagnostics.
United States market for Sexually Transmitted Diseases (STD) Diagnostics is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Sexually Transmitted Diseases (STD) Diagnostics is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Sexually Transmitted Diseases (STD) Diagnostics is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Sexually Transmitted Diseases (STD) Diagnostics players cover F.Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., Hologic Inc., Creative Diagnostics, Abbott Laboratories, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Sexually Transmitted Diseases (STD) Diagnostics market by product type, application, key players and key regions and countries.
Segmentation by Type:
The global Sexually Transmitted Diseases (STD) Diagnostics market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.
LPI (LP Information)' newest research report, the “Sexually Transmitted Diseases (STD) Diagnostics Industry Forecast” looks at past sales and reviews total world Sexually Transmitted Diseases (STD) Diagnostics sales in 2022, providing a comprehensive analysis by region and market sector of projected Sexually Transmitted Diseases (STD) Diagnostics sales for 2023 through 2029. With Sexually Transmitted Diseases (STD) Diagnostics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Sexually Transmitted Diseases (STD) Diagnostics industry.
This Insight Report provides a comprehensive analysis of the global Sexually Transmitted Diseases (STD) Diagnostics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Sexually Transmitted Diseases (STD) Diagnostics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Sexually Transmitted Diseases (STD) Diagnostics market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Sexually Transmitted Diseases (STD) Diagnostics and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Sexually Transmitted Diseases (STD) Diagnostics.
United States market for Sexually Transmitted Diseases (STD) Diagnostics is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Sexually Transmitted Diseases (STD) Diagnostics is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Sexually Transmitted Diseases (STD) Diagnostics is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Sexually Transmitted Diseases (STD) Diagnostics players cover F.Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., Hologic Inc., Creative Diagnostics, Abbott Laboratories, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Sexually Transmitted Diseases (STD) Diagnostics market by product type, application, key players and key regions and countries.
Segmentation by Type:
- Molecular Test
- Serologic Test
- Point of Care Test
- Others
- Hospital
- Clinic
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Molecular Test
- Serologic Test
- Point of Care Test
- Others
- Hospital
- Clinic
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- F.Hoffmann-La Roche Ltd
- Thermo Fisher Scientific Inc.
- Hologic Inc.
- Creative Diagnostics
- Abbott Laboratories
- Quest Diagnostics
- BD
- QIAGEN
- Cepheid
- bioMerieux Inc.
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Sexually Transmitted Diseases (STD) Diagnostics Market Size 2019-2030
2.1.2 Sexually Transmitted Diseases (STD) Diagnostics Market Size CAGR by Region (2019 VS 2023 VS 2030)
2.1.3 World Current & Future Analysis for Sexually Transmitted Diseases (STD) Diagnostics by Country/Region, 2019, 2023 & 2030
2.2 Sexually Transmitted Diseases (STD) Diagnostics Segment by Type
2.2.1 Molecular Test
2.2.2 Serologic Test
2.2.3 Point of Care Test
2.2.4 Others
2.3 Sexually Transmitted Diseases (STD) Diagnostics Market Size by Type
2.3.1 Sexually Transmitted Diseases (STD) Diagnostics Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Sexually Transmitted Diseases (STD) Diagnostics Market Size Market Share by Type (2019-2024)
2.4 Sexually Transmitted Diseases (STD) Diagnostics Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Others
2.5 Sexually Transmitted Diseases (STD) Diagnostics Market Size by Application
2.5.1 Sexually Transmitted Diseases (STD) Diagnostics Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Sexually Transmitted Diseases (STD) Diagnostics Market Size Market Share by Application (2019-2024)
3 SEXUALLY TRANSMITTED DISEASES (STD) DIAGNOSTICS MARKET SIZE BY PLAYER
3.1 Sexually Transmitted Diseases (STD) Diagnostics Market Size Market Share by Player
3.1.1 Global Sexually Transmitted Diseases (STD) Diagnostics Revenue by Player (2019-2024)
3.1.2 Global Sexually Transmitted Diseases (STD) Diagnostics Revenue Market Share by Player (2019-2024)
3.2 Global Sexually Transmitted Diseases (STD) Diagnostics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 SEXUALLY TRANSMITTED DISEASES (STD) DIAGNOSTICS BY REGION
4.1 Sexually Transmitted Diseases (STD) Diagnostics Market Size by Region (2019-2024)
4.2 Global Sexually Transmitted Diseases (STD) Diagnostics Annual Revenue by Country/Region (2019-2024)
4.3 Americas Sexually Transmitted Diseases (STD) Diagnostics Market Size Growth (2019-2024)
4.4 APAC Sexually Transmitted Diseases (STD) Diagnostics Market Size Growth (2019-2024)
4.5 Europe Sexually Transmitted Diseases (STD) Diagnostics Market Size Growth (2019-2024)
4.6 Middle East & Africa Sexually Transmitted Diseases (STD) Diagnostics Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Sexually Transmitted Diseases (STD) Diagnostics Market Size by Country (2019-2024)
5.2 Americas Sexually Transmitted Diseases (STD) Diagnostics Market Size by Type (2019-2024)
5.3 Americas Sexually Transmitted Diseases (STD) Diagnostics Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Sexually Transmitted Diseases (STD) Diagnostics Market Size by Region (2019-2024)
6.2 APAC Sexually Transmitted Diseases (STD) Diagnostics Market Size by Type (2019-2024)
6.3 APAC Sexually Transmitted Diseases (STD) Diagnostics Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Sexually Transmitted Diseases (STD) Diagnostics Market Size by Country (2019-2024)
7.2 Europe Sexually Transmitted Diseases (STD) Diagnostics Market Size by Type (2019-2024)
7.3 Europe Sexually Transmitted Diseases (STD) Diagnostics Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Sexually Transmitted Diseases (STD) Diagnostics by Region (2019-2024)
8.2 Middle East & Africa Sexually Transmitted Diseases (STD) Diagnostics Market Size by Type (2019-2024)
8.3 Middle East & Africa Sexually Transmitted Diseases (STD) Diagnostics Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL SEXUALLY TRANSMITTED DISEASES (STD) DIAGNOSTICS MARKET FORECAST
10.1 Global Sexually Transmitted Diseases (STD) Diagnostics Forecast by Region (2025-2030)
10.1.1 Global Sexually Transmitted Diseases (STD) Diagnostics Forecast by Region (2025-2030)
10.1.2 Americas Sexually Transmitted Diseases (STD) Diagnostics Forecast
10.1.3 APAC Sexually Transmitted Diseases (STD) Diagnostics Forecast
10.1.4 Europe Sexually Transmitted Diseases (STD) Diagnostics Forecast
10.1.5 Middle East & Africa Sexually Transmitted Diseases (STD) Diagnostics Forecast
10.2 Americas Sexually Transmitted Diseases (STD) Diagnostics Forecast by Country (2025-2030)
10.2.1 United States Market Sexually Transmitted Diseases (STD) Diagnostics Forecast
10.2.2 Canada Market Sexually Transmitted Diseases (STD) Diagnostics Forecast
10.2.3 Mexico Market Sexually Transmitted Diseases (STD) Diagnostics Forecast
10.2.4 Brazil Market Sexually Transmitted Diseases (STD) Diagnostics Forecast
10.3 APAC Sexually Transmitted Diseases (STD) Diagnostics Forecast by Region (2025-2030)
10.3.1 China Sexually Transmitted Diseases (STD) Diagnostics Market Forecast
10.3.2 Japan Market Sexually Transmitted Diseases (STD) Diagnostics Forecast
10.3.3 Korea Market Sexually Transmitted Diseases (STD) Diagnostics Forecast
10.3.4 Southeast Asia Market Sexually Transmitted Diseases (STD) Diagnostics Forecast
10.3.5 India Market Sexually Transmitted Diseases (STD) Diagnostics Forecast
10.3.6 Australia Market Sexually Transmitted Diseases (STD) Diagnostics Forecast
10.4 Europe Sexually Transmitted Diseases (STD) Diagnostics Forecast by Country (2025-2030)
10.4.1 Germany Market Sexually Transmitted Diseases (STD) Diagnostics Forecast
10.4.2 France Market Sexually Transmitted Diseases (STD) Diagnostics Forecast
10.4.3 UK Market Sexually Transmitted Diseases (STD) Diagnostics Forecast
10.4.4 Italy Market Sexually Transmitted Diseases (STD) Diagnostics Forecast
10.4.5 Russia Market Sexually Transmitted Diseases (STD) Diagnostics Forecast
10.5 Middle East & Africa Sexually Transmitted Diseases (STD) Diagnostics Forecast by Region (2025-2030)
10.5.1 Egypt Market Sexually Transmitted Diseases (STD) Diagnostics Forecast
10.5.2 South Africa Market Sexually Transmitted Diseases (STD) Diagnostics Forecast
10.5.3 Israel Market Sexually Transmitted Diseases (STD) Diagnostics Forecast
10.5.4 Turkey Market Sexually Transmitted Diseases (STD) Diagnostics Forecast
10.6 Global Sexually Transmitted Diseases (STD) Diagnostics Forecast by Type (2025-2030)
10.7 Global Sexually Transmitted Diseases (STD) Diagnostics Forecast by Application (2025-2030)
10.7.1 GCC Countries Market Sexually Transmitted Diseases (STD) Diagnostics Forecast
11 KEY PLAYERS ANALYSIS
11.1 F.Hoffmann-La Roche Ltd
11.1.1 F.Hoffmann-La Roche Ltd Company Information
11.1.2 F.Hoffmann-La Roche Ltd Sexually Transmitted Diseases (STD) Diagnostics Product Offered
11.1.3 F.Hoffmann-La Roche Ltd Sexually Transmitted Diseases (STD) Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 F.Hoffmann-La Roche Ltd Main Business Overview
11.1.5 F.Hoffmann-La Roche Ltd Latest Developments
11.2 Thermo Fisher Scientific Inc.
11.2.1 Thermo Fisher Scientific Inc. Company Information
11.2.2 Thermo Fisher Scientific Inc. Sexually Transmitted Diseases (STD) Diagnostics Product Offered
11.2.3 Thermo Fisher Scientific Inc. Sexually Transmitted Diseases (STD) Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Thermo Fisher Scientific Inc. Main Business Overview
11.2.5 Thermo Fisher Scientific Inc. Latest Developments
11.3 Hologic Inc.
11.3.1 Hologic Inc. Company Information
11.3.2 Hologic Inc. Sexually Transmitted Diseases (STD) Diagnostics Product Offered
11.3.3 Hologic Inc. Sexually Transmitted Diseases (STD) Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Hologic Inc. Main Business Overview
11.3.5 Hologic Inc. Latest Developments
11.4 Creative Diagnostics
11.4.1 Creative Diagnostics Company Information
11.4.2 Creative Diagnostics Sexually Transmitted Diseases (STD) Diagnostics Product Offered
11.4.3 Creative Diagnostics Sexually Transmitted Diseases (STD) Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Creative Diagnostics Main Business Overview
11.4.5 Creative Diagnostics Latest Developments
11.5 Abbott Laboratories
11.5.1 Abbott Laboratories Company Information
11.5.2 Abbott Laboratories Sexually Transmitted Diseases (STD) Diagnostics Product Offered
11.5.3 Abbott Laboratories Sexually Transmitted Diseases (STD) Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Abbott Laboratories Main Business Overview
11.5.5 Abbott Laboratories Latest Developments
11.6 Quest Diagnostics
11.6.1 Quest Diagnostics Company Information
11.6.2 Quest Diagnostics Sexually Transmitted Diseases (STD) Diagnostics Product Offered
11.6.3 Quest Diagnostics Sexually Transmitted Diseases (STD) Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Quest Diagnostics Main Business Overview
11.6.5 Quest Diagnostics Latest Developments
11.7 BD
11.7.1 BD Company Information
11.7.2 BD Sexually Transmitted Diseases (STD) Diagnostics Product Offered
11.7.3 BD Sexually Transmitted Diseases (STD) Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 BD Main Business Overview
11.7.5 BD Latest Developments
11.8 QIAGEN
11.8.1 QIAGEN Company Information
11.8.2 QIAGEN Sexually Transmitted Diseases (STD) Diagnostics Product Offered
11.8.3 QIAGEN Sexually Transmitted Diseases (STD) Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 QIAGEN Main Business Overview
11.8.5 QIAGEN Latest Developments
11.9 Cepheid
11.9.1 Cepheid Company Information
11.9.2 Cepheid Sexually Transmitted Diseases (STD) Diagnostics Product Offered
11.9.3 Cepheid Sexually Transmitted Diseases (STD) Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Cepheid Main Business Overview
11.9.5 Cepheid Latest Developments
11.10 bioMerieux Inc.
11.10.1 bioMerieux Inc. Company Information
11.10.2 bioMerieux Inc. Sexually Transmitted Diseases (STD) Diagnostics Product Offered
11.10.3 bioMerieux Inc. Sexually Transmitted Diseases (STD) Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 bioMerieux Inc. Main Business Overview
11.10.5 bioMerieux Inc. Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Sexually Transmitted Diseases (STD) Diagnostics Market Size 2019-2030
2.1.2 Sexually Transmitted Diseases (STD) Diagnostics Market Size CAGR by Region (2019 VS 2023 VS 2030)
2.1.3 World Current & Future Analysis for Sexually Transmitted Diseases (STD) Diagnostics by Country/Region, 2019, 2023 & 2030
2.2 Sexually Transmitted Diseases (STD) Diagnostics Segment by Type
2.2.1 Molecular Test
2.2.2 Serologic Test
2.2.3 Point of Care Test
2.2.4 Others
2.3 Sexually Transmitted Diseases (STD) Diagnostics Market Size by Type
2.3.1 Sexually Transmitted Diseases (STD) Diagnostics Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Sexually Transmitted Diseases (STD) Diagnostics Market Size Market Share by Type (2019-2024)
2.4 Sexually Transmitted Diseases (STD) Diagnostics Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Others
2.5 Sexually Transmitted Diseases (STD) Diagnostics Market Size by Application
2.5.1 Sexually Transmitted Diseases (STD) Diagnostics Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Sexually Transmitted Diseases (STD) Diagnostics Market Size Market Share by Application (2019-2024)
3 SEXUALLY TRANSMITTED DISEASES (STD) DIAGNOSTICS MARKET SIZE BY PLAYER
3.1 Sexually Transmitted Diseases (STD) Diagnostics Market Size Market Share by Player
3.1.1 Global Sexually Transmitted Diseases (STD) Diagnostics Revenue by Player (2019-2024)
3.1.2 Global Sexually Transmitted Diseases (STD) Diagnostics Revenue Market Share by Player (2019-2024)
3.2 Global Sexually Transmitted Diseases (STD) Diagnostics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 SEXUALLY TRANSMITTED DISEASES (STD) DIAGNOSTICS BY REGION
4.1 Sexually Transmitted Diseases (STD) Diagnostics Market Size by Region (2019-2024)
4.2 Global Sexually Transmitted Diseases (STD) Diagnostics Annual Revenue by Country/Region (2019-2024)
4.3 Americas Sexually Transmitted Diseases (STD) Diagnostics Market Size Growth (2019-2024)
4.4 APAC Sexually Transmitted Diseases (STD) Diagnostics Market Size Growth (2019-2024)
4.5 Europe Sexually Transmitted Diseases (STD) Diagnostics Market Size Growth (2019-2024)
4.6 Middle East & Africa Sexually Transmitted Diseases (STD) Diagnostics Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Sexually Transmitted Diseases (STD) Diagnostics Market Size by Country (2019-2024)
5.2 Americas Sexually Transmitted Diseases (STD) Diagnostics Market Size by Type (2019-2024)
5.3 Americas Sexually Transmitted Diseases (STD) Diagnostics Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Sexually Transmitted Diseases (STD) Diagnostics Market Size by Region (2019-2024)
6.2 APAC Sexually Transmitted Diseases (STD) Diagnostics Market Size by Type (2019-2024)
6.3 APAC Sexually Transmitted Diseases (STD) Diagnostics Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Sexually Transmitted Diseases (STD) Diagnostics Market Size by Country (2019-2024)
7.2 Europe Sexually Transmitted Diseases (STD) Diagnostics Market Size by Type (2019-2024)
7.3 Europe Sexually Transmitted Diseases (STD) Diagnostics Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Sexually Transmitted Diseases (STD) Diagnostics by Region (2019-2024)
8.2 Middle East & Africa Sexually Transmitted Diseases (STD) Diagnostics Market Size by Type (2019-2024)
8.3 Middle East & Africa Sexually Transmitted Diseases (STD) Diagnostics Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL SEXUALLY TRANSMITTED DISEASES (STD) DIAGNOSTICS MARKET FORECAST
10.1 Global Sexually Transmitted Diseases (STD) Diagnostics Forecast by Region (2025-2030)
10.1.1 Global Sexually Transmitted Diseases (STD) Diagnostics Forecast by Region (2025-2030)
10.1.2 Americas Sexually Transmitted Diseases (STD) Diagnostics Forecast
10.1.3 APAC Sexually Transmitted Diseases (STD) Diagnostics Forecast
10.1.4 Europe Sexually Transmitted Diseases (STD) Diagnostics Forecast
10.1.5 Middle East & Africa Sexually Transmitted Diseases (STD) Diagnostics Forecast
10.2 Americas Sexually Transmitted Diseases (STD) Diagnostics Forecast by Country (2025-2030)
10.2.1 United States Market Sexually Transmitted Diseases (STD) Diagnostics Forecast
10.2.2 Canada Market Sexually Transmitted Diseases (STD) Diagnostics Forecast
10.2.3 Mexico Market Sexually Transmitted Diseases (STD) Diagnostics Forecast
10.2.4 Brazil Market Sexually Transmitted Diseases (STD) Diagnostics Forecast
10.3 APAC Sexually Transmitted Diseases (STD) Diagnostics Forecast by Region (2025-2030)
10.3.1 China Sexually Transmitted Diseases (STD) Diagnostics Market Forecast
10.3.2 Japan Market Sexually Transmitted Diseases (STD) Diagnostics Forecast
10.3.3 Korea Market Sexually Transmitted Diseases (STD) Diagnostics Forecast
10.3.4 Southeast Asia Market Sexually Transmitted Diseases (STD) Diagnostics Forecast
10.3.5 India Market Sexually Transmitted Diseases (STD) Diagnostics Forecast
10.3.6 Australia Market Sexually Transmitted Diseases (STD) Diagnostics Forecast
10.4 Europe Sexually Transmitted Diseases (STD) Diagnostics Forecast by Country (2025-2030)
10.4.1 Germany Market Sexually Transmitted Diseases (STD) Diagnostics Forecast
10.4.2 France Market Sexually Transmitted Diseases (STD) Diagnostics Forecast
10.4.3 UK Market Sexually Transmitted Diseases (STD) Diagnostics Forecast
10.4.4 Italy Market Sexually Transmitted Diseases (STD) Diagnostics Forecast
10.4.5 Russia Market Sexually Transmitted Diseases (STD) Diagnostics Forecast
10.5 Middle East & Africa Sexually Transmitted Diseases (STD) Diagnostics Forecast by Region (2025-2030)
10.5.1 Egypt Market Sexually Transmitted Diseases (STD) Diagnostics Forecast
10.5.2 South Africa Market Sexually Transmitted Diseases (STD) Diagnostics Forecast
10.5.3 Israel Market Sexually Transmitted Diseases (STD) Diagnostics Forecast
10.5.4 Turkey Market Sexually Transmitted Diseases (STD) Diagnostics Forecast
10.6 Global Sexually Transmitted Diseases (STD) Diagnostics Forecast by Type (2025-2030)
10.7 Global Sexually Transmitted Diseases (STD) Diagnostics Forecast by Application (2025-2030)
10.7.1 GCC Countries Market Sexually Transmitted Diseases (STD) Diagnostics Forecast
11 KEY PLAYERS ANALYSIS
11.1 F.Hoffmann-La Roche Ltd
11.1.1 F.Hoffmann-La Roche Ltd Company Information
11.1.2 F.Hoffmann-La Roche Ltd Sexually Transmitted Diseases (STD) Diagnostics Product Offered
11.1.3 F.Hoffmann-La Roche Ltd Sexually Transmitted Diseases (STD) Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 F.Hoffmann-La Roche Ltd Main Business Overview
11.1.5 F.Hoffmann-La Roche Ltd Latest Developments
11.2 Thermo Fisher Scientific Inc.
11.2.1 Thermo Fisher Scientific Inc. Company Information
11.2.2 Thermo Fisher Scientific Inc. Sexually Transmitted Diseases (STD) Diagnostics Product Offered
11.2.3 Thermo Fisher Scientific Inc. Sexually Transmitted Diseases (STD) Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Thermo Fisher Scientific Inc. Main Business Overview
11.2.5 Thermo Fisher Scientific Inc. Latest Developments
11.3 Hologic Inc.
11.3.1 Hologic Inc. Company Information
11.3.2 Hologic Inc. Sexually Transmitted Diseases (STD) Diagnostics Product Offered
11.3.3 Hologic Inc. Sexually Transmitted Diseases (STD) Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Hologic Inc. Main Business Overview
11.3.5 Hologic Inc. Latest Developments
11.4 Creative Diagnostics
11.4.1 Creative Diagnostics Company Information
11.4.2 Creative Diagnostics Sexually Transmitted Diseases (STD) Diagnostics Product Offered
11.4.3 Creative Diagnostics Sexually Transmitted Diseases (STD) Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Creative Diagnostics Main Business Overview
11.4.5 Creative Diagnostics Latest Developments
11.5 Abbott Laboratories
11.5.1 Abbott Laboratories Company Information
11.5.2 Abbott Laboratories Sexually Transmitted Diseases (STD) Diagnostics Product Offered
11.5.3 Abbott Laboratories Sexually Transmitted Diseases (STD) Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Abbott Laboratories Main Business Overview
11.5.5 Abbott Laboratories Latest Developments
11.6 Quest Diagnostics
11.6.1 Quest Diagnostics Company Information
11.6.2 Quest Diagnostics Sexually Transmitted Diseases (STD) Diagnostics Product Offered
11.6.3 Quest Diagnostics Sexually Transmitted Diseases (STD) Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Quest Diagnostics Main Business Overview
11.6.5 Quest Diagnostics Latest Developments
11.7 BD
11.7.1 BD Company Information
11.7.2 BD Sexually Transmitted Diseases (STD) Diagnostics Product Offered
11.7.3 BD Sexually Transmitted Diseases (STD) Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 BD Main Business Overview
11.7.5 BD Latest Developments
11.8 QIAGEN
11.8.1 QIAGEN Company Information
11.8.2 QIAGEN Sexually Transmitted Diseases (STD) Diagnostics Product Offered
11.8.3 QIAGEN Sexually Transmitted Diseases (STD) Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 QIAGEN Main Business Overview
11.8.5 QIAGEN Latest Developments
11.9 Cepheid
11.9.1 Cepheid Company Information
11.9.2 Cepheid Sexually Transmitted Diseases (STD) Diagnostics Product Offered
11.9.3 Cepheid Sexually Transmitted Diseases (STD) Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Cepheid Main Business Overview
11.9.5 Cepheid Latest Developments
11.10 bioMerieux Inc.
11.10.1 bioMerieux Inc. Company Information
11.10.2 bioMerieux Inc. Sexually Transmitted Diseases (STD) Diagnostics Product Offered
11.10.3 bioMerieux Inc. Sexually Transmitted Diseases (STD) Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 bioMerieux Inc. Main Business Overview
11.10.5 bioMerieux Inc. Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Sexually Transmitted Diseases (STD) Diagnostics Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ millions)
Table 2. Sexually Transmitted Diseases (STD) Diagnostics Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Molecular Test
Table 4. Major Players of Serologic Test
Table 5. Major Players of Point of Care Test
Table 6. Major Players of Others
Table 7. Sexually Transmitted Diseases (STD) Diagnostics Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ millions)
Table 8. Global Sexually Transmitted Diseases (STD) Diagnostics Market Size by Type (2019-2024) & ($ millions)
Table 9. Global Sexually Transmitted Diseases (STD) Diagnostics Market Size Market Share by Type (2019-2024)
Table 10. Sexually Transmitted Diseases (STD) Diagnostics Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ millions)
Table 11. Global Sexually Transmitted Diseases (STD) Diagnostics Market Size by Application (2019-2024) & ($ millions)
Table 12. Global Sexually Transmitted Diseases (STD) Diagnostics Market Size Market Share by Application (2019-2024)
Table 13. Global Sexually Transmitted Diseases (STD) Diagnostics Revenue by Player (2019-2024) & ($ millions)
Table 14. Global Sexually Transmitted Diseases (STD) Diagnostics Revenue Market Share by Player (2019-2024)
Table 15. Sexually Transmitted Diseases (STD) Diagnostics Key Players Head office and Products Offered
Table 16. Sexually Transmitted Diseases (STD) Diagnostics Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 17. New Products and Potential Entrants
Table 18. Mergers & Acquisitions, Expansion
Table 19. Global Sexually Transmitted Diseases (STD) Diagnostics Market Size by Region (2019-2024) & ($ millions)
Table 20. Global Sexually Transmitted Diseases (STD) Diagnostics Market Size Market Share by Region (2019-2024)
Table 21. Global Sexually Transmitted Diseases (STD) Diagnostics Revenue by Country/Region (2019-2024) & ($ millions)
Table 22. Global Sexually Transmitted Diseases (STD) Diagnostics Revenue Market Share by Country/Region (2019-2024)
Table 23. Americas Sexually Transmitted Diseases (STD) Diagnostics Market Size by Country (2019-2024) & ($ millions)
Table 24. Americas Sexually Transmitted Diseases (STD) Diagnostics Market Size Market Share by Country (2019-2024)
Table 25. Americas Sexually Transmitted Diseases (STD) Diagnostics Market Size by Type (2019-2024) & ($ millions)
Table 26. Americas Sexually Transmitted Diseases (STD) Diagnostics Market Size Market Share by Type (2019-2024)
Table 27. Americas Sexually Transmitted Diseases (STD) Diagnostics Market Size by Application (2019-2024) & ($ millions)
Table 28. Americas Sexually Transmitted Diseases (STD) Diagnostics Market Size Market Share by Application (2019-2024)
Table 29. APAC Sexually Transmitted Diseases (STD) Diagnostics Market Size by Region (2019-2024) & ($ millions)
Table 30. APAC Sexually Transmitted Diseases (STD) Diagnostics Market Size Market Share by Region (2019-2024)
Table 31. APAC Sexually Transmitted Diseases (STD) Diagnostics Market Size by Type (2019-2024) & ($ millions)
Table 32. APAC Sexually Transmitted Diseases (STD) Diagnostics Market Size by Application (2019-2024) & ($ millions)
Table 33. Europe Sexually Transmitted Diseases (STD) Diagnostics Market Size by Country (2019-2024) & ($ millions)
Table 34. Europe Sexually Transmitted Diseases (STD) Diagnostics Market Size Market Share by Country (2019-2024)
Table 35. Europe Sexually Transmitted Diseases (STD) Diagnostics Market Size by Type (2019-2024) & ($ millions)
Table 36. Europe Sexually Transmitted Diseases (STD) Diagnostics Market Size by Application (2019-2024) & ($ millions)
Table 37. Middle East & Africa Sexually Transmitted Diseases (STD) Diagnostics Market Size by Region (2019-2024) & ($ millions)
Table 38. Middle East & Africa Sexually Transmitted Diseases (STD) Diagnostics Market Size by Type (2019-2024) & ($ millions)
Table 39. Middle East & Africa Sexually Transmitted Diseases (STD) Diagnostics Market Size by Application (2019-2024) & ($ millions)
Table 40. Key Market Drivers & Growth Opportunities of Sexually Transmitted Diseases (STD) Diagnostics
Table 41. Key Market Challenges & Risks of Sexually Transmitted Diseases (STD) Diagnostics
Table 42. Key Industry Trends of Sexually Transmitted Diseases (STD) Diagnostics
Table 43. Global Sexually Transmitted Diseases (STD) Diagnostics Market Size Forecast by Region (2025-2030) & ($ millions)
Table 44. Global Sexually Transmitted Diseases (STD) Diagnostics Market Size Market Share Forecast by Region (2025-2030)
Table 45. Global Sexually Transmitted Diseases (STD) Diagnostics Market Size Forecast by Type (2025-2030) & ($ millions)
Table 46. Global Sexually Transmitted Diseases (STD) Diagnostics Market Size Forecast by Application (2025-2030) & ($ millions)
Table 47. F.Hoffmann-La Roche Ltd Details, Company Type, Sexually Transmitted Diseases (STD) Diagnostics Area Served and Its Competitors
Table 48. F.Hoffmann-La Roche Ltd Sexually Transmitted Diseases (STD) Diagnostics Product Offered
Table 49. F.Hoffmann-La Roche Ltd Sexually Transmitted Diseases (STD) Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 50. F.Hoffmann-La Roche Ltd Main Business
Table 51. F.Hoffmann-La Roche Ltd Latest Developments
Table 52. Thermo Fisher Scientific Inc. Details, Company Type, Sexually Transmitted Diseases (STD) Diagnostics Area Served and Its Competitors
Table 53. Thermo Fisher Scientific Inc. Sexually Transmitted Diseases (STD) Diagnostics Product Offered
Table 54. Thermo Fisher Scientific Inc. Sexually Transmitted Diseases (STD) Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 55. Thermo Fisher Scientific Inc. Main Business
Table 56. Thermo Fisher Scientific Inc. Latest Developments
Table 57. Hologic Inc. Details, Company Type, Sexually Transmitted Diseases (STD) Diagnostics Area Served and Its Competitors
Table 58. Hologic Inc. Sexually Transmitted Diseases (STD) Diagnostics Product Offered
Table 59. Hologic Inc. Sexually Transmitted Diseases (STD) Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 60. Hologic Inc. Main Business
Table 61. Hologic Inc. Latest Developments
Table 62. Creative Diagnostics Details, Company Type, Sexually Transmitted Diseases (STD) Diagnostics Area Served and Its Competitors
Table 63. Creative Diagnostics Sexually Transmitted Diseases (STD) Diagnostics Product Offered
Table 64. Creative Diagnostics Sexually Transmitted Diseases (STD) Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 65. Creative Diagnostics Main Business
Table 66. Creative Diagnostics Latest Developments
Table 67. Abbott Laboratories Details, Company Type, Sexually Transmitted Diseases (STD) Diagnostics Area Served and Its Competitors
Table 68. Abbott Laboratories Sexually Transmitted Diseases (STD) Diagnostics Product Offered
Table 69. Abbott Laboratories Sexually Transmitted Diseases (STD) Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 70. Abbott Laboratories Main Business
Table 71. Abbott Laboratories Latest Developments
Table 72. Quest Diagnostics Details, Company Type, Sexually Transmitted Diseases (STD) Diagnostics Area Served and Its Competitors
Table 73. Quest Diagnostics Sexually Transmitted Diseases (STD) Diagnostics Product Offered
Table 74. Quest Diagnostics Sexually Transmitted Diseases (STD) Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 75. Quest Diagnostics Main Business
Table 76. Quest Diagnostics Latest Developments
Table 77. BD Details, Company Type, Sexually Transmitted Diseases (STD) Diagnostics Area Served and Its Competitors
Table 78. BD Sexually Transmitted Diseases (STD) Diagnostics Product Offered
Table 79. BD Sexually Transmitted Diseases (STD) Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 80. BD Main Business
Table 81. BD Latest Developments
Table 82. QIAGEN Details, Company Type, Sexually Transmitted Diseases (STD) Diagnostics Area Served and Its Competitors
Table 83. QIAGEN Sexually Transmitted Diseases (STD) Diagnostics Product Offered
Table 84. QIAGEN Sexually Transmitted Diseases (STD) Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 85. QIAGEN Main Business
Table 86. QIAGEN Latest Developments
Table 87. Cepheid Details, Company Type, Sexually Transmitted Diseases (STD) Diagnostics Area Served and Its Competitors
Table 88. Cepheid Sexually Transmitted Diseases (STD) Diagnostics Product Offered
Table 89. Cepheid Sexually Transmitted Diseases (STD) Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 90. Cepheid Main Business
Table 91. Cepheid Latest Developments
Table 92. bioMerieux Inc. Details, Company Type, Sexually Transmitted Diseases (STD) Diagnostics Area Served and Its Competitors
Table 93. bioMerieux Inc. Sexually Transmitted Diseases (STD) Diagnostics Product Offered
Table 94. bioMerieux Inc. Sexually Transmitted Diseases (STD) Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 95. bioMerieux Inc. Main Business
Table 96. bioMerieux Inc. Latest Developments
Table 1. Sexually Transmitted Diseases (STD) Diagnostics Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ millions)
Table 2. Sexually Transmitted Diseases (STD) Diagnostics Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Molecular Test
Table 4. Major Players of Serologic Test
Table 5. Major Players of Point of Care Test
Table 6. Major Players of Others
Table 7. Sexually Transmitted Diseases (STD) Diagnostics Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ millions)
Table 8. Global Sexually Transmitted Diseases (STD) Diagnostics Market Size by Type (2019-2024) & ($ millions)
Table 9. Global Sexually Transmitted Diseases (STD) Diagnostics Market Size Market Share by Type (2019-2024)
Table 10. Sexually Transmitted Diseases (STD) Diagnostics Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ millions)
Table 11. Global Sexually Transmitted Diseases (STD) Diagnostics Market Size by Application (2019-2024) & ($ millions)
Table 12. Global Sexually Transmitted Diseases (STD) Diagnostics Market Size Market Share by Application (2019-2024)
Table 13. Global Sexually Transmitted Diseases (STD) Diagnostics Revenue by Player (2019-2024) & ($ millions)
Table 14. Global Sexually Transmitted Diseases (STD) Diagnostics Revenue Market Share by Player (2019-2024)
Table 15. Sexually Transmitted Diseases (STD) Diagnostics Key Players Head office and Products Offered
Table 16. Sexually Transmitted Diseases (STD) Diagnostics Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 17. New Products and Potential Entrants
Table 18. Mergers & Acquisitions, Expansion
Table 19. Global Sexually Transmitted Diseases (STD) Diagnostics Market Size by Region (2019-2024) & ($ millions)
Table 20. Global Sexually Transmitted Diseases (STD) Diagnostics Market Size Market Share by Region (2019-2024)
Table 21. Global Sexually Transmitted Diseases (STD) Diagnostics Revenue by Country/Region (2019-2024) & ($ millions)
Table 22. Global Sexually Transmitted Diseases (STD) Diagnostics Revenue Market Share by Country/Region (2019-2024)
Table 23. Americas Sexually Transmitted Diseases (STD) Diagnostics Market Size by Country (2019-2024) & ($ millions)
Table 24. Americas Sexually Transmitted Diseases (STD) Diagnostics Market Size Market Share by Country (2019-2024)
Table 25. Americas Sexually Transmitted Diseases (STD) Diagnostics Market Size by Type (2019-2024) & ($ millions)
Table 26. Americas Sexually Transmitted Diseases (STD) Diagnostics Market Size Market Share by Type (2019-2024)
Table 27. Americas Sexually Transmitted Diseases (STD) Diagnostics Market Size by Application (2019-2024) & ($ millions)
Table 28. Americas Sexually Transmitted Diseases (STD) Diagnostics Market Size Market Share by Application (2019-2024)
Table 29. APAC Sexually Transmitted Diseases (STD) Diagnostics Market Size by Region (2019-2024) & ($ millions)
Table 30. APAC Sexually Transmitted Diseases (STD) Diagnostics Market Size Market Share by Region (2019-2024)
Table 31. APAC Sexually Transmitted Diseases (STD) Diagnostics Market Size by Type (2019-2024) & ($ millions)
Table 32. APAC Sexually Transmitted Diseases (STD) Diagnostics Market Size by Application (2019-2024) & ($ millions)
Table 33. Europe Sexually Transmitted Diseases (STD) Diagnostics Market Size by Country (2019-2024) & ($ millions)
Table 34. Europe Sexually Transmitted Diseases (STD) Diagnostics Market Size Market Share by Country (2019-2024)
Table 35. Europe Sexually Transmitted Diseases (STD) Diagnostics Market Size by Type (2019-2024) & ($ millions)
Table 36. Europe Sexually Transmitted Diseases (STD) Diagnostics Market Size by Application (2019-2024) & ($ millions)
Table 37. Middle East & Africa Sexually Transmitted Diseases (STD) Diagnostics Market Size by Region (2019-2024) & ($ millions)
Table 38. Middle East & Africa Sexually Transmitted Diseases (STD) Diagnostics Market Size by Type (2019-2024) & ($ millions)
Table 39. Middle East & Africa Sexually Transmitted Diseases (STD) Diagnostics Market Size by Application (2019-2024) & ($ millions)
Table 40. Key Market Drivers & Growth Opportunities of Sexually Transmitted Diseases (STD) Diagnostics
Table 41. Key Market Challenges & Risks of Sexually Transmitted Diseases (STD) Diagnostics
Table 42. Key Industry Trends of Sexually Transmitted Diseases (STD) Diagnostics
Table 43. Global Sexually Transmitted Diseases (STD) Diagnostics Market Size Forecast by Region (2025-2030) & ($ millions)
Table 44. Global Sexually Transmitted Diseases (STD) Diagnostics Market Size Market Share Forecast by Region (2025-2030)
Table 45. Global Sexually Transmitted Diseases (STD) Diagnostics Market Size Forecast by Type (2025-2030) & ($ millions)
Table 46. Global Sexually Transmitted Diseases (STD) Diagnostics Market Size Forecast by Application (2025-2030) & ($ millions)
Table 47. F.Hoffmann-La Roche Ltd Details, Company Type, Sexually Transmitted Diseases (STD) Diagnostics Area Served and Its Competitors
Table 48. F.Hoffmann-La Roche Ltd Sexually Transmitted Diseases (STD) Diagnostics Product Offered
Table 49. F.Hoffmann-La Roche Ltd Sexually Transmitted Diseases (STD) Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 50. F.Hoffmann-La Roche Ltd Main Business
Table 51. F.Hoffmann-La Roche Ltd Latest Developments
Table 52. Thermo Fisher Scientific Inc. Details, Company Type, Sexually Transmitted Diseases (STD) Diagnostics Area Served and Its Competitors
Table 53. Thermo Fisher Scientific Inc. Sexually Transmitted Diseases (STD) Diagnostics Product Offered
Table 54. Thermo Fisher Scientific Inc. Sexually Transmitted Diseases (STD) Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 55. Thermo Fisher Scientific Inc. Main Business
Table 56. Thermo Fisher Scientific Inc. Latest Developments
Table 57. Hologic Inc. Details, Company Type, Sexually Transmitted Diseases (STD) Diagnostics Area Served and Its Competitors
Table 58. Hologic Inc. Sexually Transmitted Diseases (STD) Diagnostics Product Offered
Table 59. Hologic Inc. Sexually Transmitted Diseases (STD) Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 60. Hologic Inc. Main Business
Table 61. Hologic Inc. Latest Developments
Table 62. Creative Diagnostics Details, Company Type, Sexually Transmitted Diseases (STD) Diagnostics Area Served and Its Competitors
Table 63. Creative Diagnostics Sexually Transmitted Diseases (STD) Diagnostics Product Offered
Table 64. Creative Diagnostics Sexually Transmitted Diseases (STD) Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 65. Creative Diagnostics Main Business
Table 66. Creative Diagnostics Latest Developments
Table 67. Abbott Laboratories Details, Company Type, Sexually Transmitted Diseases (STD) Diagnostics Area Served and Its Competitors
Table 68. Abbott Laboratories Sexually Transmitted Diseases (STD) Diagnostics Product Offered
Table 69. Abbott Laboratories Sexually Transmitted Diseases (STD) Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 70. Abbott Laboratories Main Business
Table 71. Abbott Laboratories Latest Developments
Table 72. Quest Diagnostics Details, Company Type, Sexually Transmitted Diseases (STD) Diagnostics Area Served and Its Competitors
Table 73. Quest Diagnostics Sexually Transmitted Diseases (STD) Diagnostics Product Offered
Table 74. Quest Diagnostics Sexually Transmitted Diseases (STD) Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 75. Quest Diagnostics Main Business
Table 76. Quest Diagnostics Latest Developments
Table 77. BD Details, Company Type, Sexually Transmitted Diseases (STD) Diagnostics Area Served and Its Competitors
Table 78. BD Sexually Transmitted Diseases (STD) Diagnostics Product Offered
Table 79. BD Sexually Transmitted Diseases (STD) Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 80. BD Main Business
Table 81. BD Latest Developments
Table 82. QIAGEN Details, Company Type, Sexually Transmitted Diseases (STD) Diagnostics Area Served and Its Competitors
Table 83. QIAGEN Sexually Transmitted Diseases (STD) Diagnostics Product Offered
Table 84. QIAGEN Sexually Transmitted Diseases (STD) Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 85. QIAGEN Main Business
Table 86. QIAGEN Latest Developments
Table 87. Cepheid Details, Company Type, Sexually Transmitted Diseases (STD) Diagnostics Area Served and Its Competitors
Table 88. Cepheid Sexually Transmitted Diseases (STD) Diagnostics Product Offered
Table 89. Cepheid Sexually Transmitted Diseases (STD) Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 90. Cepheid Main Business
Table 91. Cepheid Latest Developments
Table 92. bioMerieux Inc. Details, Company Type, Sexually Transmitted Diseases (STD) Diagnostics Area Served and Its Competitors
Table 93. bioMerieux Inc. Sexually Transmitted Diseases (STD) Diagnostics Product Offered
Table 94. bioMerieux Inc. Sexually Transmitted Diseases (STD) Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 95. bioMerieux Inc. Main Business
Table 96. bioMerieux Inc. Latest Developments
LIST OF FIGURES
Figure 1. Sexually Transmitted Diseases (STD) Diagnostics Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Sexually Transmitted Diseases (STD) Diagnostics Market Size Growth Rate 2019-2030 ($ millions)
Figure 6. Sexually Transmitted Diseases (STD) Diagnostics Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Sexually Transmitted Diseases (STD) Diagnostics Sales Market Share by Country/Region (2023)
Figure 8. Sexually Transmitted Diseases (STD) Diagnostics Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Sexually Transmitted Diseases (STD) Diagnostics Market Size Market Share by Type in 2023
Figure 10. Sexually Transmitted Diseases (STD) Diagnostics in Hospital
Figure 11. Global Sexually Transmitted Diseases (STD) Diagnostics Market: Hospital (2019-2024) & ($ millions)
Figure 12. Sexually Transmitted Diseases (STD) Diagnostics in Clinic
Figure 13. Global Sexually Transmitted Diseases (STD) Diagnostics Market: Clinic (2019-2024) & ($ millions)
Figure 14. Sexually Transmitted Diseases (STD) Diagnostics in Others
Figure 15. Global Sexually Transmitted Diseases (STD) Diagnostics Market: Others (2019-2024) & ($ millions)
Figure 16. Global Sexually Transmitted Diseases (STD) Diagnostics Market Size Market Share by Application in 2023
Figure 17. Global Sexually Transmitted Diseases (STD) Diagnostics Revenue Market Share by Player in 2023
Figure 18. Global Sexually Transmitted Diseases (STD) Diagnostics Market Size Market Share by Region (2019-2024)
Figure 19. Americas Sexually Transmitted Diseases (STD) Diagnostics Market Size 2019-2024 ($ millions)
Figure 20. APAC Sexually Transmitted Diseases (STD) Diagnostics Market Size 2019-2024 ($ millions)
Figure 21. Europe Sexually Transmitted Diseases (STD) Diagnostics Market Size 2019-2024 ($ millions)
Figure 22. Middle East & Africa Sexually Transmitted Diseases (STD) Diagnostics Market Size 2019-2024 ($ millions)
Figure 23. Americas Sexually Transmitted Diseases (STD) Diagnostics Value Market Share by Country in 2023
Figure 24. United States Sexually Transmitted Diseases (STD) Diagnostics Market Size Growth 2019-2024 ($ millions)
Figure 25. Canada Sexually Transmitted Diseases (STD) Diagnostics Market Size Growth 2019-2024 ($ millions)
Figure 26. Mexico Sexually Transmitted Diseases (STD) Diagnostics Market Size Growth 2019-2024 ($ millions)
Figure 27. Brazil Sexually Transmitted Diseases (STD) Diagnostics Market Size Growth 2019-2024 ($ millions)
Figure 28. APAC Sexually Transmitted Diseases (STD) Diagnostics Market Size Market Share by Region in 2023
Figure 29. APAC Sexually Transmitted Diseases (STD) Diagnostics Market Size Market Share by Type (2019-2024)
Figure 30. APAC Sexually Transmitted Diseases (STD) Diagnostics Market Size Market Share by Application (2019-2024)
Figure 31. China Sexually Transmitted Diseases (STD) Diagnostics Market Size Growth 2019-2024 ($ millions)
Figure 32. Japan Sexually Transmitted Diseases (STD) Diagnostics Market Size Growth 2019-2024 ($ millions)
Figure 33. South Korea Sexually Transmitted Diseases (STD) Diagnostics Market Size Growth 2019-2024 ($ millions)
Figure 34. Southeast Asia Sexually Transmitted Diseases (STD) Diagnostics Market Size Growth 2019-2024 ($ millions)
Figure 35. India Sexually Transmitted Diseases (STD) Diagnostics Market Size Growth 2019-2024 ($ millions)
Figure 36. Australia Sexually Transmitted Diseases (STD) Diagnostics Market Size Growth 2019-2024 ($ millions)
Figure 37. Europe Sexually Transmitted Diseases (STD) Diagnostics Market Size Market Share by Country in 2023
Figure 38. Europe Sexually Transmitted Diseases (STD) Diagnostics Market Size Market Share by Type (2019-2024)
Figure 39. Europe Sexually Transmitted Diseases (STD) Diagnostics Market Size Market Share by Application (2019-2024)
Figure 40. Germany Sexually Transmitted Diseases (STD) Diagnostics Market Size Growth 2019-2024 ($ millions)
Figure 41. France Sexually Transmitted Diseases (STD) Diagnostics Market Size Growth 2019-2024 ($ millions)
Figure 42. UK Sexually Transmitted Diseases (STD) Diagnostics Market Size Growth 2019-2024 ($ millions)
Figure 43. Italy Sexually Transmitted Diseases (STD) Diagnostics Market Size Growth 2019-2024 ($ millions)
Figure 44. Russia Sexually Transmitted Diseases (STD) Diagnostics Market Size Growth 2019-2024 ($ millions)
Figure 45. Middle East & Africa Sexually Transmitted Diseases (STD) Diagnostics Market Size Market Share by Region (2019-2024)
Figure 46. Middle East & Africa Sexually Transmitted Diseases (STD) Diagnostics Market Size Market Share by Type (2019-2024)
Figure 47. Middle East & Africa Sexually Transmitted Diseases (STD) Diagnostics Market Size Market Share by Application (2019-2024)
Figure 48. Egypt Sexually Transmitted Diseases (STD) Diagnostics Market Size Growth 2019-2024 ($ millions)
Figure 49. South Africa Sexually Transmitted Diseases (STD) Diagnostics Market Size Growth 2019-2024 ($ millions)
Figure 50. Israel Sexually Transmitted Diseases (STD) Diagnostics Market Size Growth 2019-2024 ($ millions)
Figure 51. Turkey Sexually Transmitted Diseases (STD) Diagnostics Market Size Growth 2019-2024 ($ millions)
Figure 52. GCC Countries Sexually Transmitted Diseases (STD) Diagnostics Market Size Growth 2019-2024 ($ millions)
Figure 53. Americas Sexually Transmitted Diseases (STD) Diagnostics Market Size 2025-2030 ($ millions)
Figure 54. APAC Sexually Transmitted Diseases (STD) Diagnostics Market Size 2025-2030 ($ millions)
Figure 55. Europe Sexually Transmitted Diseases (STD) Diagnostics Market Size 2025-2030 ($ millions)
Figure 56. Middle East & Africa Sexually Transmitted Diseases (STD) Diagnostics Market Size 2025-2030 ($ millions)
Figure 57. United States Sexually Transmitted Diseases (STD) Diagnostics Market Size 2025-2030 ($ millions)
Figure 58. Canada Sexually Transmitted Diseases (STD) Diagnostics Market Size 2025-2030 ($ millions)
Figure 59. Mexico Sexually Transmitted Diseases (STD) Diagnostics Market Size 2025-2030 ($ millions)
Figure 60. Brazil Sexually Transmitted Diseases (STD) Diagnostics Market Size 2025-2030 ($ millions)
Figure 61. China Sexually Transmitted Diseases (STD) Diagnostics Market Size 2025-2030 ($ millions)
Figure 62. Japan Sexually Transmitted Diseases (STD) Diagnostics Market Size 2025-2030 ($ millions)
Figure 63. Korea Sexually Transmitted Diseases (STD) Diagnostics Market Size 2025-2030 ($ millions)
Figure 64. Southeast Asia Sexually Transmitted Diseases (STD) Diagnostics Market Size 2025-2030 ($ millions)
Figure 65. India Sexually Transmitted Diseases (STD) Diagnostics Market Size 2025-2030 ($ millions)
Figure 66. Australia Sexually Transmitted Diseases (STD) Diagnostics Market Size 2025-2030 ($ millions)
Figure 67. Germany Sexually Transmitted Diseases (STD) Diagnostics Market Size 2025-2030 ($ millions)
Figure 68. France Sexually Transmitted Diseases (STD) Diagnostics Market Size 2025-2030 ($ millions)
Figure 69. UK Sexually Transmitted Diseases (STD) Diagnostics Market Size 2025-2030 ($ millions)
Figure 70. Italy Sexually Transmitted Diseases (STD) Diagnostics Market Size 2025-2030 ($ millions)
Figure 71. Russia Sexually Transmitted Diseases (STD) Diagnostics Market Size 2025-2030 ($ millions)
Figure 72. Egypt Sexually Transmitted Diseases (STD) Diagnostics Market Size 2025-2030 ($ millions)
Figure 73. South Africa Sexually Transmitted Diseases (STD) Diagnostics Market Size 2025-2030 ($ millions)
Figure 74. Israel Sexually Transmitted Diseases (STD) Diagnostics Market Size 2025-2030 ($ millions)
Figure 75. Turkey Sexually Transmitted Diseases (STD) Diagnostics Market Size 2025-2030 ($ millions)
Figure 76. GCC Countries Sexually Transmitted Diseases (STD) Diagnostics Market Size 2025-2030 ($ millions)
Figure 77. Global Sexually Transmitted Diseases (STD) Diagnostics Market Size Market Share Forecast by Type (2025-2030)
Figure 78. Global Sexually Transmitted Diseases (STD) Diagnostics Market Size Market Share Forecast by Application (2025-2030)
Figure 1. Sexually Transmitted Diseases (STD) Diagnostics Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Sexually Transmitted Diseases (STD) Diagnostics Market Size Growth Rate 2019-2030 ($ millions)
Figure 6. Sexually Transmitted Diseases (STD) Diagnostics Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Sexually Transmitted Diseases (STD) Diagnostics Sales Market Share by Country/Region (2023)
Figure 8. Sexually Transmitted Diseases (STD) Diagnostics Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Sexually Transmitted Diseases (STD) Diagnostics Market Size Market Share by Type in 2023
Figure 10. Sexually Transmitted Diseases (STD) Diagnostics in Hospital
Figure 11. Global Sexually Transmitted Diseases (STD) Diagnostics Market: Hospital (2019-2024) & ($ millions)
Figure 12. Sexually Transmitted Diseases (STD) Diagnostics in Clinic
Figure 13. Global Sexually Transmitted Diseases (STD) Diagnostics Market: Clinic (2019-2024) & ($ millions)
Figure 14. Sexually Transmitted Diseases (STD) Diagnostics in Others
Figure 15. Global Sexually Transmitted Diseases (STD) Diagnostics Market: Others (2019-2024) & ($ millions)
Figure 16. Global Sexually Transmitted Diseases (STD) Diagnostics Market Size Market Share by Application in 2023
Figure 17. Global Sexually Transmitted Diseases (STD) Diagnostics Revenue Market Share by Player in 2023
Figure 18. Global Sexually Transmitted Diseases (STD) Diagnostics Market Size Market Share by Region (2019-2024)
Figure 19. Americas Sexually Transmitted Diseases (STD) Diagnostics Market Size 2019-2024 ($ millions)
Figure 20. APAC Sexually Transmitted Diseases (STD) Diagnostics Market Size 2019-2024 ($ millions)
Figure 21. Europe Sexually Transmitted Diseases (STD) Diagnostics Market Size 2019-2024 ($ millions)
Figure 22. Middle East & Africa Sexually Transmitted Diseases (STD) Diagnostics Market Size 2019-2024 ($ millions)
Figure 23. Americas Sexually Transmitted Diseases (STD) Diagnostics Value Market Share by Country in 2023
Figure 24. United States Sexually Transmitted Diseases (STD) Diagnostics Market Size Growth 2019-2024 ($ millions)
Figure 25. Canada Sexually Transmitted Diseases (STD) Diagnostics Market Size Growth 2019-2024 ($ millions)
Figure 26. Mexico Sexually Transmitted Diseases (STD) Diagnostics Market Size Growth 2019-2024 ($ millions)
Figure 27. Brazil Sexually Transmitted Diseases (STD) Diagnostics Market Size Growth 2019-2024 ($ millions)
Figure 28. APAC Sexually Transmitted Diseases (STD) Diagnostics Market Size Market Share by Region in 2023
Figure 29. APAC Sexually Transmitted Diseases (STD) Diagnostics Market Size Market Share by Type (2019-2024)
Figure 30. APAC Sexually Transmitted Diseases (STD) Diagnostics Market Size Market Share by Application (2019-2024)
Figure 31. China Sexually Transmitted Diseases (STD) Diagnostics Market Size Growth 2019-2024 ($ millions)
Figure 32. Japan Sexually Transmitted Diseases (STD) Diagnostics Market Size Growth 2019-2024 ($ millions)
Figure 33. South Korea Sexually Transmitted Diseases (STD) Diagnostics Market Size Growth 2019-2024 ($ millions)
Figure 34. Southeast Asia Sexually Transmitted Diseases (STD) Diagnostics Market Size Growth 2019-2024 ($ millions)
Figure 35. India Sexually Transmitted Diseases (STD) Diagnostics Market Size Growth 2019-2024 ($ millions)
Figure 36. Australia Sexually Transmitted Diseases (STD) Diagnostics Market Size Growth 2019-2024 ($ millions)
Figure 37. Europe Sexually Transmitted Diseases (STD) Diagnostics Market Size Market Share by Country in 2023
Figure 38. Europe Sexually Transmitted Diseases (STD) Diagnostics Market Size Market Share by Type (2019-2024)
Figure 39. Europe Sexually Transmitted Diseases (STD) Diagnostics Market Size Market Share by Application (2019-2024)
Figure 40. Germany Sexually Transmitted Diseases (STD) Diagnostics Market Size Growth 2019-2024 ($ millions)
Figure 41. France Sexually Transmitted Diseases (STD) Diagnostics Market Size Growth 2019-2024 ($ millions)
Figure 42. UK Sexually Transmitted Diseases (STD) Diagnostics Market Size Growth 2019-2024 ($ millions)
Figure 43. Italy Sexually Transmitted Diseases (STD) Diagnostics Market Size Growth 2019-2024 ($ millions)
Figure 44. Russia Sexually Transmitted Diseases (STD) Diagnostics Market Size Growth 2019-2024 ($ millions)
Figure 45. Middle East & Africa Sexually Transmitted Diseases (STD) Diagnostics Market Size Market Share by Region (2019-2024)
Figure 46. Middle East & Africa Sexually Transmitted Diseases (STD) Diagnostics Market Size Market Share by Type (2019-2024)
Figure 47. Middle East & Africa Sexually Transmitted Diseases (STD) Diagnostics Market Size Market Share by Application (2019-2024)
Figure 48. Egypt Sexually Transmitted Diseases (STD) Diagnostics Market Size Growth 2019-2024 ($ millions)
Figure 49. South Africa Sexually Transmitted Diseases (STD) Diagnostics Market Size Growth 2019-2024 ($ millions)
Figure 50. Israel Sexually Transmitted Diseases (STD) Diagnostics Market Size Growth 2019-2024 ($ millions)
Figure 51. Turkey Sexually Transmitted Diseases (STD) Diagnostics Market Size Growth 2019-2024 ($ millions)
Figure 52. GCC Countries Sexually Transmitted Diseases (STD) Diagnostics Market Size Growth 2019-2024 ($ millions)
Figure 53. Americas Sexually Transmitted Diseases (STD) Diagnostics Market Size 2025-2030 ($ millions)
Figure 54. APAC Sexually Transmitted Diseases (STD) Diagnostics Market Size 2025-2030 ($ millions)
Figure 55. Europe Sexually Transmitted Diseases (STD) Diagnostics Market Size 2025-2030 ($ millions)
Figure 56. Middle East & Africa Sexually Transmitted Diseases (STD) Diagnostics Market Size 2025-2030 ($ millions)
Figure 57. United States Sexually Transmitted Diseases (STD) Diagnostics Market Size 2025-2030 ($ millions)
Figure 58. Canada Sexually Transmitted Diseases (STD) Diagnostics Market Size 2025-2030 ($ millions)
Figure 59. Mexico Sexually Transmitted Diseases (STD) Diagnostics Market Size 2025-2030 ($ millions)
Figure 60. Brazil Sexually Transmitted Diseases (STD) Diagnostics Market Size 2025-2030 ($ millions)
Figure 61. China Sexually Transmitted Diseases (STD) Diagnostics Market Size 2025-2030 ($ millions)
Figure 62. Japan Sexually Transmitted Diseases (STD) Diagnostics Market Size 2025-2030 ($ millions)
Figure 63. Korea Sexually Transmitted Diseases (STD) Diagnostics Market Size 2025-2030 ($ millions)
Figure 64. Southeast Asia Sexually Transmitted Diseases (STD) Diagnostics Market Size 2025-2030 ($ millions)
Figure 65. India Sexually Transmitted Diseases (STD) Diagnostics Market Size 2025-2030 ($ millions)
Figure 66. Australia Sexually Transmitted Diseases (STD) Diagnostics Market Size 2025-2030 ($ millions)
Figure 67. Germany Sexually Transmitted Diseases (STD) Diagnostics Market Size 2025-2030 ($ millions)
Figure 68. France Sexually Transmitted Diseases (STD) Diagnostics Market Size 2025-2030 ($ millions)
Figure 69. UK Sexually Transmitted Diseases (STD) Diagnostics Market Size 2025-2030 ($ millions)
Figure 70. Italy Sexually Transmitted Diseases (STD) Diagnostics Market Size 2025-2030 ($ millions)
Figure 71. Russia Sexually Transmitted Diseases (STD) Diagnostics Market Size 2025-2030 ($ millions)
Figure 72. Egypt Sexually Transmitted Diseases (STD) Diagnostics Market Size 2025-2030 ($ millions)
Figure 73. South Africa Sexually Transmitted Diseases (STD) Diagnostics Market Size 2025-2030 ($ millions)
Figure 74. Israel Sexually Transmitted Diseases (STD) Diagnostics Market Size 2025-2030 ($ millions)
Figure 75. Turkey Sexually Transmitted Diseases (STD) Diagnostics Market Size 2025-2030 ($ millions)
Figure 76. GCC Countries Sexually Transmitted Diseases (STD) Diagnostics Market Size 2025-2030 ($ millions)
Figure 77. Global Sexually Transmitted Diseases (STD) Diagnostics Market Size Market Share Forecast by Type (2025-2030)
Figure 78. Global Sexually Transmitted Diseases (STD) Diagnostics Market Size Market Share Forecast by Application (2025-2030)
